Hemorrhagic Myocardial Infarction Detection by Biomarkers
- Conditions
- Acute Myocardial Infarction
- Registration Number
- NCT05872308
- Lead Sponsor
- Indiana University
- Brief Summary
Pilot trial to determine diagnostic efficacy of post-reperfusion troponin kinetics in detection of hemorrhagic myocardial infarction
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 227
- Age ≥ 18 years
- Index STEMI
- Coronary angiogram with PCI to occur irrespective of the onset of the symptoms.
- Ability to provide informed consent for themselves
- History of prior myocardial infarction,
- Cardiogenic shock,
- Patients who present with current cardiac arrest
- Any contraindication to cardiac CMR (claustrophobia, pacemaker or cardiac defibrillator, known allergy to gadolinium),
- Presence of permanent atrial fibrillation,
- Unconscious patient,
- Severe renal insufficiency (creatinine clearance ≤ 30 ml/min/m2 or renal replacement therapy),
- Women who are pregnant or breastfeeding. Women of reproductive potential must have a negative pregnancy test.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic Threshold 48 hours Levels of markers in hemorrhagic infarct vs. non-hemorrhagic infarct
- Secondary Outcome Measures
Name Time Method Peak levels of serum troponin-I 48 hours peak levels of serum troponin-I in hemorrhagic infarct vs non-hemorrhagic infarct
Hemorrhagic infarct microvascular obstruction 48 hours as determined by cardiac MRI
Area under the curve (AUC) for serum troponin-I 48 hours area under the curve post-MI for troponin-I
Hemorrhagic infarct volume 48 hours as determined by cardiac MRI
Hemorrhagic infarct area at risk 48 hours as determined by cardiac MRI
Hemorrhagic infarct size 48 hours as determined by cardiac MRI
Trial Locations
- Locations (2)
IU Methodist Hospital
🇺🇸Indianapolis, Indiana, United States
Synergy Superspecialty Hospital
🇮🇳Rājkot, India